1.63
前日終値:
$1.64
開ける:
$1.67
24時間の取引高:
68,705
Relative Volume:
0.31
時価総額:
$18.87M
収益:
$996.00K
当期純損益:
$-6.09M
株価収益率:
-3.0755
EPS:
-0.53
ネットキャッシュフロー:
$-9.76M
1週間 パフォーマンス:
-4.12%
1か月 パフォーマンス:
-4.12%
6か月 パフォーマンス:
+40.52%
1年 パフォーマンス:
+89.53%
Therapeuticsmd Inc Stock (TXMD) Company Profile
名前
Therapeuticsmd Inc
セクター
電話
561-961-1900
住所
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
TXMD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TXMD
Therapeuticsmd Inc
|
1.63 | 18.98M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
125.82 | 55.71B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.59 | 49.38B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.11 | 44.89B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.21 | 35.96B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
487.25 | 21.36B | 3.08B | 1.24B | 1.07B | 25.61 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-08-07 | ダウングレード | Jefferies | Hold → Underperform |
| 2020-05-19 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2019-12-02 | 開始されました | Guggenheim | Buy |
| 2019-10-17 | 開始されました | H.C. Wainwright | Buy |
| 2019-04-30 | 再開されました | Noble Capital Markets | Outperform |
| 2018-06-15 | 開始されました | JP Morgan | Overweight |
| 2017-09-08 | 開始されました | Morgan Stanley | Equal-Weight |
| 2017-07-11 | アップグレード | Oppenheimer | Perform → Outperform |
| 2017-05-09 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2016-11-22 | 再開されました | Jefferies | Buy |
| 2016-11-22 | 開始されました | Oppenheimer | Outperform |
| 2016-11-07 | 再開されました | Guggenheim | Buy |
| 2016-04-04 | 開始されました | Goldman | Buy |
| 2015-12-08 | 繰り返されました | Jefferies | Buy |
| 2015-12-08 | 繰り返されました | Stifel | Buy |
| 2015-09-21 | 繰り返されました | Jefferies | Buy |
| 2015-06-09 | 開始されました | Guggenheim | Buy |
| 2014-07-08 | 開始されました | FBR Capital | Outperform |
| 2014-04-17 | 繰り返されました | Noble Financial | Buy |
| 2014-01-28 | 繰り返されました | Noble Financial | Buy |
すべてを表示
Therapeuticsmd Inc (TXMD) 最新ニュース
Fund Flows: Why TherapeuticsMD Inc stock could be next big winnerMarket Sentiment Review & Stepwise Entry/Exit Trade Alerts - moha.gov.vn
TherapeuticsMD Inc. Stock Slips 3.4%, Underperforms Market - 富途牛牛
TherapeuticsMD Inc. Stock Rallies 3.7%, Outperforms Market - 富途牛牛
TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why hedge funds are buying TherapeuticsMD Inc. stockWeekly Trade Report & Intraday High Probability Setup Alerts - Улправда
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
Is TherapeuticsMD Inc. stock a safe haven assetJuly 2025 Opening Moves & Target Return Focused Stock Picks - Bölüm Sonu Canavarı
Rate Cut: Will TherapeuticsMD Inc. stock deliver long term returnsEarnings Overview Report & AI Powered Market Entry Strategies - Улправда
How strong is TherapeuticsMD Inc. stock revenue growthGlobal Markets & AI Driven Stock Reports - DonanımHaber
MSN Money - MSN
Block Trades: How currency fluctuations impact TherapeuticsMD Inc. stock2025 Momentum Check & Advanced Technical Analysis Signals - ulpravda.ru
How supply chain issues affect TherapeuticsMD Inc. stockJuly 2025 Highlights & Long-Term Capital Growth Strategies - Улправда
Dilution adjustment of TherapeuticsMD, Inc. – FWB:29TA - TradingView — Track All Markets
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Approves Key Proposals at Annual Meeting - TipRanks
TherapeuticsMD (NASDAQ: TXMD) investors approve 2025 votes, 640M share authorization - Stock Titan
Price to earnings ratio of TherapeuticsMD, Inc. – DUS:29TA - TradingView — Track All Markets
29TA Stock Price and Chart — DUS:29TA - TradingView — Track All Markets
TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Dip Buying: Is TherapeuticsMD Inc stock attractive for income investorsIPO Watch & AI Based Trade Execution Alerts - moha.gov.vn
With TherapeuticsMD Stock Surging, Have You Considered The Downside? - Trefis
TherapeuticsMD (TXMD) Stock Analysis Report | Financials & Insights - Benzinga
TherapeuticsMD, Inc. (TXMD) -6.3% in After-hours: Price Decline Despite Recent Results - Stocks Telegraph
Will TherapeuticsMD Inc. (29TA) stock profit from automation waveEarnings Miss & Weekly Watchlist of Top Performers - Newser
Will TherapeuticsMD Inc. (29TA) stock sustain bullish trend into 2025Trade Risk Summary & Safe Entry Zone Identification - Newser
Can TherapeuticsMD Inc. (29TA) stock test all time highsJuly 2025 Setups & Step-by-Step Trade Execution Guides - Newser
Is TherapeuticsMD Inc. stock affected by interest rate hikes - Newser
TherapeuticsMD Inc. Stock Sheds 3.9%, Underperforms Market - 富途牛牛
TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
TherapeuticsMD Announces Pricing of Offering of Common Stock - AOL.com
TherapeuticsMD, Inc. (TXMD) 5.48% in After-hours: What’s Driving the Move? - Stocks Telegraph
TherapeuticsMD Inc Stock Analysis and ForecastCandlestick Trading Patterns & Low Risk Trading Plans - earlytimes.in
TherapeuticsMD Inc. Stock Falls 7.9%, Underperforms Market - 富途牛牛
What drives TherapeuticsMD Inc 29TA stock priceSupport Zone Identification & High Return Stock Ideas - earlytimes.in
Is TherapeuticsMD Inc. stock a buy before product launchesWeekly Trade Report & Weekly Breakout Watchlists - newser.com
Is TherapeuticsMD Inc. (29TA) stock supported by strong fundamentalsAnalyst Downgrade & Expert Curated Trade Ideas - newser.com
Can TherapeuticsMD Inc. stock hit analyst price targets2025 Earnings Surprises & Verified High Yield Trade Plans - newser.com
Will TherapeuticsMD Inc. (29TA) stock outperform energy sector in 2025Portfolio Update Summary & AI Enhanced Trading Signals - newser.com
Will TherapeuticsMD Inc. (29TA) stock hit Wall Street targetsPortfolio Performance Summary & Risk Controlled Swing Alerts - newser.com
How TherapeuticsMD Inc. (29TA) stock responds to bond marketMarket Volume Summary & Consistent Return Investment Signals - newser.com
Therapeuticsmd Inc (TXMD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):